MVM was founded in 1997 and manages four funds totalling more than US$700 million. MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.
Website:mvm.com
Industries:
Health Care
Medical
Medical Device
Biotechnology
Commercial
Health Diagnostics
Pharmaceutical
Consumer
Dental
Wellness
Life Science
Hardware
Logistics
Supply Chain Management
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
London, England, United Kingdom
Contact information:
